CA2246896C - Immunoassay utilizing two incubations with labelled antigen - Google Patents

Immunoassay utilizing two incubations with labelled antigen Download PDF

Info

Publication number
CA2246896C
CA2246896C CA002246896A CA2246896A CA2246896C CA 2246896 C CA2246896 C CA 2246896C CA 002246896 A CA002246896 A CA 002246896A CA 2246896 A CA2246896 A CA 2246896A CA 2246896 C CA2246896 C CA 2246896C
Authority
CA
Canada
Prior art keywords
immunoassay
antigen
infectious agent
immobilised
labelled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002246896A
Other languages
English (en)
French (fr)
Other versions
CA2246896A1 (en
Inventor
Justin Mark Glover
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of CA2246896A1 publication Critical patent/CA2246896A1/en
Application granted granted Critical
Publication of CA2246896C publication Critical patent/CA2246896C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
CA002246896A 1997-09-11 1998-09-08 Immunoassay utilizing two incubations with labelled antigen Expired - Lifetime CA2246896C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9719357.7A GB9719357D0 (en) 1997-09-11 1997-09-11 Immunoassay Utilizing Two Incubations With Labelled Antigen
GB9719357.7 1997-09-11
US09/141,887 US6121006A (en) 1997-09-11 1998-08-28 Immunoassay utilizing two incubations with labeled antigen

Publications (2)

Publication Number Publication Date
CA2246896A1 CA2246896A1 (en) 1999-03-11
CA2246896C true CA2246896C (en) 2006-04-04

Family

ID=26312227

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002246896A Expired - Lifetime CA2246896C (en) 1997-09-11 1998-09-08 Immunoassay utilizing two incubations with labelled antigen

Country Status (10)

Country Link
US (1) US6121006A (enExample)
EP (1) EP0902286B1 (enExample)
JP (1) JPH11148936A (enExample)
AT (1) ATE254286T1 (enExample)
CA (1) CA2246896C (enExample)
DE (1) DE69819643T2 (enExample)
DK (1) DK0902286T3 (enExample)
ES (1) ES2210678T3 (enExample)
GB (1) GB9719357D0 (enExample)
PT (1) PT902286E (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458528B1 (en) 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
CA2446246A1 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US7262019B2 (en) * 2001-05-03 2007-08-28 Immunetics, Inc. System and methods for detection of Bacillus anthracis related analytes in biological fluids
GB0128583D0 (en) * 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes
US7514191B2 (en) * 2006-04-26 2009-04-07 Xerox Corporation Imaging member
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
HRP20180607T1 (hr) 2011-06-10 2019-04-05 Oregon Health & Science University Glikoproteini i rekombinantni vektori cmv
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
KR101990958B1 (ko) * 2016-08-31 2019-06-21 휴마시스 주식회사 면역학적 측정을 이용한 hiv 1형, 2형 및 o형 동시 진단용 키트 및 이를 이용한 동시 진단방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789628A (en) * 1986-06-16 1988-12-06 Vxr, Inc. Devices for carrying out ligand/anti-ligand assays, methods of using such devices and diagnostic reagents and kits incorporating such devices
EP0366673B1 (en) * 1987-06-09 1992-09-16 Cambridge Life Sciences Plc Immunoassay method
DE3854834T2 (de) * 1987-10-30 1996-06-27 Abbott Lab Immuntest unter Verwendung von Antigenen, produziert in heterologen Organismen
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
DE4120412C1 (enExample) * 1991-06-20 1993-01-07 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De

Also Published As

Publication number Publication date
ES2210678T3 (es) 2004-07-01
DE69819643D1 (de) 2003-12-18
PT902286E (pt) 2004-03-31
GB9719357D0 (en) 1997-11-12
EP0902286A2 (en) 1999-03-17
CA2246896A1 (en) 1999-03-11
EP0902286A3 (en) 2000-02-23
DK0902286T3 (da) 2004-02-02
JPH11148936A (ja) 1999-06-02
EP0902286B1 (en) 2003-11-12
DE69819643T2 (de) 2004-12-02
ATE254286T1 (de) 2003-11-15
US6121006A (en) 2000-09-19

Similar Documents

Publication Publication Date Title
CA2246896C (en) Immunoassay utilizing two incubations with labelled antigen
EP0461462A1 (en) Solid phase Immunoassay
JP3398199B2 (ja) 塩基解離アッセイ
EP0644950A4 (en) ASSAY FOR THE DETECTION OF HIV ANTIGEN AND HIV ANTIBODIES.
WO1994024560A1 (en) Immunoassay
US5081010A (en) Extraction composition, test kit and their use to extract or determine herpes simplex viral antigen
US6489131B1 (en) Interference reduction by rheumatoid factors
EP1898216A2 (en) Diagnostic reagent and diagnostic reagent kit for HIV infection, method for manufacturing diagnostic reagent for HIV infection and method for detecting anti-HIV antibody
AU6879291A (en) Combination assay for antibody or antigen
JPH0743384B2 (ja) アッセイ用水性洗浄液、診断試験キット及び単純ヘルペスウイルスの測定方法
JP2011520124A (ja) ウイルスを検出するための方法
WO1999060401A1 (en) Immunoassay reagents and immunoassay method
WO1995002186A1 (en) New diagnostic assay for detection of syphilis
JPH11507635A (ja) Ｈｉｖを検出するためのペプチド
Kiefer et al. Normalized enzyme-linked immunosorbent assay for determining immunoglobulin G antibodies to cytomegalovirus
Ornopia et al. Detection of anti‐hepatitis C virus using chemiluminescence
Sommerfelt et al. A simple semi-rapid HIV-1&2 confirmatory immunoassay using magnetic particles
EP0627625A1 (en) Immunoassay for differential diagnosis
WO1995034812A1 (en) METHOD OF ASSAYING SPECIFIC IgM ANTIBODY AND REAGENT THEREFOR
JPH06265548A (ja) 抗原と抗体の同時測定法
Wienhues et al. Boehringer Mannheim modular test concepts in HIV and hepatitis immunoassays
KR920007205B1 (ko) 단순 포진 비루스 항원 측정용 세정 조성물, 테스트 키트 및 그 사용법
JP2001318098A (ja) アルカリ処理したウシ血清アルブミンを用いた免疫測定方法

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180910